CHINA SXT PHARMACEUTICALS IN (SXTC) Stock Balance Sheet
NASDAQ:SXTC • VGG2161P1650
Current stock price
1.89 USD
-0.24 (-11.27%)
At close:
1.9 USD
+0.01 (+0.53%)
After Hours:
| MRQ (2025-9-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 21.17M | 18.10M | 12.07M | 17.37M | 15.52M | |||
| Receivables | 2.87M | 1.90M | 1.35M | 1.34M | 5.53M | |||
| Inventories | 751.40K | 828.10K | 794.90K | 530.00K | 1.02M | |||
| Other Current Assets | 1.26M | 469.30K | 21.70K | 280.00K | 380.00K | |||
| Total Current Assets | 26.04M | 21.30M | 14.23M | 19.52M | 22.45M | |||
| Non-Current Assets | ||||||||
| PPE Net | 302.40K | 355.20K | 564.70K | 1.27M | 1.59M | |||
| Intangibles | 8.50K | 11.80K | 19.10K | 30.00K | 40.00K | |||
| Other Non-Current Assets | N/A | 0.00 | 8.31M | 8.74M | 9.46M | |||
| Total Non-Current Assets | 310.90K | 367.00K | 8.89M | 10.03M | 11.10M | |||
| TOTAL ASSETS | 26.35M | 21.66M | 23.13M | 29.55M | 33.55M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 976.40K | 702.20K | 493.10K | 170.00K | 0.00 | |||
| Current Portion Of LT Debt. | 4.50K | 8.80K | 1.80M | 3.17M | 2.05M | |||
| Accrued Expenses | 1.24M | 1.22M | 1.50M | 1.12M | 970.00K | |||
| Accounts Payable | 530.70K | 1.16M | 1.28M | 1.38M | 1.48M | |||
| Other Current Liabilities | 3.21M | 2.92M | 3.83M | 8.67M | 12.62M | |||
| Total Current Liabilities | 5.96M | 6.01M | 8.90M | 14.50M | 17.12M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 73.10K | 96.30K | 117.10K | 120.00K | 0.00 | |||
| Other Non-Current Liabilities | 85.20K | 115.40K | 177.50K | 250.00K | N/A | |||
| Total Non-Current Liabilities | 158.30K | 211.70K | 294.70K | 360.00K | 0.00 | |||
| TOTAL LIABILITIES | 6.12M | 6.22M | 9.20M | 14.86M | 17.12M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -34.38M | -28.02M | -24.71M | -21.61M | -15.69M | |||
| Additional Paid In Capital | N/A | 0.00 | 35.32M | 35.59M | 30.99M | |||
| Common Shares | 55.38M | 44.53M | 4.35M | 910.00K | 160.00K | |||
| Other Shareholders' Equity | -767.00K | -1.08M | -1.03M | -200.00K | 960.00K | |||
| Shares Outstanding | 773.90K | 91.80K | 1.90K | 400.00 | 100.00 | |||
| Tangible Book Value per Share | 26.13 | 168.06 | 7.52K | 38.58K | 234.00K | |||
| Total Shareholders' Equity | 20.23M | 15.44M | 13.93M | 14.69M | 16.42M | |||
| TOTAL LIABILITIES AND EQUITY | 26.35M | 21.66M | 23.13M | 29.55M | 33.55M | |||
| Statistics | ||||||||
| Debt/Equity | 0.05 | 0.05 | 0.04 | 0.02 | N/A | |||
| Current Ratio | 4.37 | 3.54 | 1.60 | 1.35 | 1.31 | |||
| Return On Assets (ROA) | -33.66% | -15.25% | -13.40% | -20.07% | -17.11% | |||
| Return On Equity (ROE) | -43.84% | -21.40% | -22.24% | -40.37% | -34.96% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21